Bill is the Co-chair of the Life Sciences Practice Group. He has extensive experience representing issuers, investors, and investment banks in structuring and executing IPOs, cross-over investments, alternative public offerings, including APOs, reverse mergers and Form 10 transactions, follow-on public offerings, CMPOs, registered directs, PIPEs, and private placements. Bill represents hedge funds, venture capital firms, and private equity firms in customized investments in public companies, including structured PIPEs and registered directs. Bill also represents public companies in public and private financings, SEC compliance, corporate governance, and general counseling.
Bill has extensive experience representing buyers and sellers in M&A transactions, including public company deals, private company deals, and spin-offs. Bill regularly represents domestic and foreign companies, and he is well-versed in issues specific to cross-border deals.
Additionally, Bill represents private companies and investors in venture capital transactions.
viewpoints
Frequently Asked Questions for Private Companies Considering a Reverse Merger
February 13, 2024 | Article | By William Hicks, John T. Rudy
A Between The Biotech Waves Conversation With William Hicks
June 10, 2022 | Podcast
News & Press
Thomson Reuters Recognizes 10 Mintz Attorneys as “Stand-out Lawyers”
February 20, 2024
Deal Watch: Where Did All the IPOs Go?
September 26, 2022
Spotlight on SPACs: The Dog Days of Summer
August 10, 2022
Mintz Practice Groups and Attorneys Garner Top Rankings in 2020 Edition of The Legal 500 United States
June 12, 2020
Events & Speaking
Navigating Biotech Funding Dynamics: Is Flat the New Up? Shifts in Public and Private Finance
LSX Inv€$tival Showcase™
London, UK
The Next Phase In US Healthcare Investment – What Have We Seen, And Where Are We Going?
LSX Investival Showcase
Virtual Event
Sustainable Ecosystem for Bio/MedTech Startups
12th New York Health Forum
Yale Club Manhattan, Trumbull & Saybrook Room, 18th Floor
Boston Biotech CEO Conference
Boston Biotech Conferences
Four Seasons Hotel, 200 Boylston Street, Boston, MA
Recognition & Awards
Recommended by The Legal 500 United States for Healthcare: Life Sciences (2020); Capital Markets: Equity (2021 – 2022)
Who’s Who Legal: Global Leader - Life Sciences (2023)
Thomson Reuters Stand-out Lawyers (2024)
Who’s Who Legal: Life Sciences: Transactional (2019)
LMG Life Sciences: Financial & Corporate, Corporate, Mergers & Acquisitions, Venture Capital US Life Sciences Star (2018-2019)